GlassScriptPhysician profile
Jacqueline Hollander
NPI 1912656117
$2,067.04
in general payments reported to CMS, 2019-2025
19 companies · $676 in 2025
The $676 reported for 2025 was more than what 77% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $353 · 2023: $882 · 2024: $156 · 2025: $676.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,714.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,714.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $362.22 | 2022-2025 | |
| Lilly USA, LLC | $299.99 | 2022-2023 | Mounjaro, Jardiance, Emgality |
| Novo Nordisk INC | $298.89 | 2022-2025 | Wegovy, Rybelsus, Ozempic |
| Bayer Healthcare Pharmaceuticals INC. | $153.16 | 2022-2023 | |
| Pfizer INC. | $136.52 | 2023-2025 | |
| Heartflow, INC. | $120.81 | 2025 | |
| Exact Sciences Corporation | $102.51 | 2023 | Cologuard Collection Kit |
| Astrazeneca Pharmaceuticals LP | $95.57 | 2022-2024 | Farxiga |
| E.R. Squibb & Sons, L.L.C. | $93.14 | 2024-2025 | Camzyos, Eliquis |
| Merck Sharp & Dohme LLC | $76.98 | 2025 | Verquvo |
| Glaxosmithkline, LLC. | $76.38 | 2022-2023 | Trelegy Ellipta, Shingrix, Arexvy |
| Boston Scientific Corporation | $70.81 | 2023-2025 | Watchman Flx, Watchman Access System, Varithena Administration Pack |
| Abbott Laboratories | $58.35 | 2022-2023 | Freestyle Libre 3, Freestyle Libre 2 |
| Alnylam Pharmaceuticals INC. | $24.57 | 2022 | |
| Urgo Medical North America, LLC | $22.25 | 2023 | Drawtex Hydroconductive Wound Dressing With Levafiber 4x4, Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Urgok2 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Idorsia Pharmaceuticals US INC | $21.59 | 2023 | Quviviq |
| Boehringer Ingelheim Pharmaceuticals, INC. | $21.00 | 2023 | Jardiance, Tradjenta |
| Abbvie INC. | $18.69 | 2024 | |
| Amgen INC. | $13.61 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacqueline Hollander listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.